Skip to main content
Clinical Trials/NCT04842214
NCT04842214
Active, not recruiting
Not Applicable

Evaluation of Disease Course in Oncological Patients During Inpatient Rehabilitation and After Three Months Follow-up: a Cohort Study.

Klinik Valens1 site in 1 country250 target enrollmentJanuary 1, 2019

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Oncologic Disorders
Sponsor
Klinik Valens
Enrollment
250
Locations
1
Primary Endpoint
Patient Reported Outcomes Measurement Information System (PROMIS)
Status
Active, not recruiting
Last Updated
3 years ago

Overview

Brief Summary

Constant improvements in the areas of diagnostics and treatment lead to an increase of patients surviving an oncological diagnosis ("cancer survivors") thus increasing the cost factor on both society and health care systems. Meta-analysis have shown the effectiveness of multidimensional rehabilitation programs concerning cost-effectiveness and for improving different health parameters. However when submitted to oncological rehabilitation in Switzerland there is no clear definition when to use which specific assessment during the different stages of oncological rehabilitation.

This cohort study aims to evaluate and systematically follow-up patients that are assigned for oncological inpatient rehabilitation at the Rehabilitation Center Walenstadtberg.

The main purposes are i) to evaluate disease onset of oncological patients during rehabilitation and to identify relationships between mobility and cancer-related fatigue at discharge; ii) to identify predictive factors for everyday functioning and social participation after three months discharge.

Registry
clinicaltrials.gov
Start Date
January 1, 2019
End Date
December 30, 2023
Last Updated
3 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
Klinik Valens
Responsible Party
Principal Investigator
Principal Investigator

Jens Bansi

Head of Research and Development

Klinik Valens

Eligibility Criteria

Inclusion Criteria

  • Diagnosed with "Cancer";
  • Literacy and understanding German language;
  • Signed informed consent;

Exclusion Criteria

  • Women who are pregnant or breastfeeding / have the intention to become pregnant during the course of the study;
  • Other clinically significant concomitant disease states (e.g. renal failure, hepatic dysfunction, cardiovascular disease, etc);
  • Known or suspected non-compliance, drug or alcohol abuse;
  • Inability to follow the procedures of the study: e.g. due to language problems, psychological disorders, dementia of the participant, etc;
  • Enrolment of the investigator, his/her family members, employees and other dependent persons;
  • Cognitive impairment: Mini-Mental State Examination (MMSE) \< 21;
  • Major Depression or Hospital Anxiety and Depression Scale (HADS) \>11 at baseline.

Outcomes

Primary Outcomes

Patient Reported Outcomes Measurement Information System (PROMIS)

Time Frame: Three months (Day 0-Day 92) with time points set after three weeks (Day 21) and three months (Day 92)

Change of participants' physical and mental health over three weeks training and after three months discharge (follow-up). The PROMIS Global-10 is a 10-item patient-reported questionnaire in which the response options are presented as 5-point (as well as a single 11-point) rating scales. The results of the questions are used to calculate two summary scores: a Global Physical Health Score and a Global Mental Health score with higher scores indication better physical and/or mental health.

Secondary Outcomes

  • Multidimensional Fatigue Inventory (MFI)(Three months (Day 0 - Day 92) with time points set after three weeks (Day 21) and three months after discharge (Day 92))
  • Six Minute Walking Test (6MWT)(Three weeks (Day 0 - Day 21))
  • Functional Independence Measure (FIM)(Three weeks (Day 0 - Day 21))
  • Timed-Up-and-Go (TUG)(Three weeks (Day 0 - Day 21))
  • Hospital Anxiety and Depression Scale (HADS)(Three weeks (Day 0 - Day 21))
  • EuroQoL-Group five dimension quality of life questionnaire (EQ-5D)(Three weeks (Day 0 - Day 21))

Study Sites (1)

Loading locations...

Similar Trials